Novus Biologicals products are now on bio-techne.com

Human Osteopontin (OPN) DuoSet ELISA, 15 Plate

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
Biotin

Order Details

Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Human Osteopontin (OPN) DuoSet ELISA, 15 Plate Summary

Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details
Gene
SPP1

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Publications
Read Publications using DY1433.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human Osteopontin (OPN) DuoSet ELISA, 15 Plate

  • BNSP
  • Bone sialoprotein 1
  • Eta-1
  • MGC110940
  • Nephropontin
  • OPN
  • Osteopontin
  • secreted phosphoprotein 1bone sialoprotein I, early T-lymphocyteactivation 1)
  • secreted phosphoprotein-1 (osteopontin, bone sialoprotein)
  • Spp1
  • SPP-1
  • SPP1/CALPHA1 fusion
  • Urinary stone protein
  • uropontin

Background

Osteopontin (OPN), also known as bone sialoprotein (BSP), is a secreted SIBLING family protein that can be variably modified by O- and N-glycosylation, sulfation, phosphorylation, and transglutamination. OPN is widely expressed and is prominent in mineralized tissues. It inhibits bone mineralization and kidney stone formation and promotes inflammation, cell ad¬hesion, and migration. Its expression is upregulat¬ed during inflammation, obesity, atherosclerosis, cancer, and tissue damage and contributes to the pathophysiology of these conditions. The central region of OPN contains RGD and non-RGD binding sites for multiple integrins. Adjacent to the RGD motif is the sequence SLAYGLR (SVVYGLR in human) which serves as a cryptic binding site for additional integrins: it is masked in full length OPN but is exposed following OPN cleavage by multiple proteases in tumors and sites of tissue injury.

Customers Who Viewed This Item Also Viewed...

MAB1419
Species: Hu, Rt
Applications: CyTOF-ready, ICC, IHC, ICFlow
4014-SP
Species: Hu
Applications: BA
AF942
Species: Mu
Applications: CyTOF-ready, ICC, IHC, ICFlow, WB
DPI00
Species: Hu
Applications: ELISA
NB110-3638
Species: Hu, Mu, Rt
Applications: ELISA, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, RI, WB
DCC270
Species: Hu
Applications: ELISA
NBP2-32263
Species: Hu, Mu
Applications: IHC, IP, WB
NBP2-92749
Species: Hu, Mu
Applications: WB
NBP1-89133
Species: Hu
Applications: ICC/IF, IHC, IHC-P, WB
NBP3-25358
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, WB
DY805
Species: Hu
Applications: ELISA
355-BM
Species: Hu, Mu, Rt
Applications: BA
BBA10
Species: Hu
Applications: CyTOF-ready, Flow, IHC, IP, Simple Western, WB
NBP1-91258
Species: Bv, Ca, Eq, Fe, Hu, Mu, Po, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
DVE00
Species: Hu
Applications: ELISA
NBP2-92546
Species: Hu, Mu
Applications: ELISA, ICC/IF, IHC, WB
M6000B
Species: Mu
Applications: ELISA
DY1433
Species: Hu
Applications: ELISA

Publications for Osteopontin/OPN (DY1433)(30)

We have publications tested in 2 confirmed species: Human, Xenograft.


Filter By Application
All Applications
Filter By Species
Human
(29)
Xenograft
(1)
All Species
Showing Publications 1 - 10 of 30. Show All 30 Publications.
Publications using DY1433 Applications Species
Kakucs, Z;Illes, Z;Hayden, Z;Berki, T;Orsi, G; Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis PloS one 2024-08-29 [PMID: 39208261] (Human) Human
Pappas, AG;Eleftheriou, K;Vlahakos, V;Magkouta, SF;Riba, T;Dede, K;Siampani, R;Kompogiorgas, S;Polydora, E;Papalampidou, A;Loutsidi, NE;Mantas, N;Tavernaraki, E;Exarchos, D;Kalomenidis, I; High Plasma Osteopontin Levels Are Associated with Serious Post-Acute-COVID-19-Related Dyspnea Journal of clinical medicine 2024-01-10 [PMID: 38256526] (Human) Human
Rehage, E;Sowislok, A;Busch, A;Papaeleftheriou, E;Jansen, M;Jäger, M; Surgical Site-Released Tissue Is Potent to Generate Bone onto TCP and PCL-TCP Scaffolds In Vitro International journal of molecular sciences 2023-11-01 [PMID: 37958857] (Human) Human
Matasariu, DR;Bausic, AIG;Mandici, CE;Bujor, IE;Cristofor, AE;Bratila, E;Lozneanu, L;Boiculese, LV;Grigore, M;Ursache, A; Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis Biomedicines 2023-07-20 [PMID: 37509675] (Human) Human
FZ Khamissi, L Ning, E Kefaloyian, H Dun, A Arthanaris, A Keller, JJ Atkinson, W Li, B Wong, S Dietmann, K Lavine, D Kreisel, A Herrlich Identification of kidney injury released circulating osteopontin as causal agent of respiratory failure Science Advances, 2022-02-25;8(8):eabm5900. 2022-02-25 [PMID: 35213222] (Human) Human
R Pohl, S Feder, EM Haberl, L Rein-Fisch, TS Weiss, M Spirk, A Bruckmann, N McMullen, CJ Sinal, C Buechler Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis Biomedicines, 2022-01-07;10(1):. 2022-01-07 [PMID: 35052810] (Human) Human
G Orsi, Z Hayden, T Cseh, T Berki, Z Illes Osteopontin levels are associated with late-time lower regional brain volumes in multiple sclerosis Scientific Reports, 2021-12-08;11(1):23604. 2021-12-08 [PMID: 34880402] (Human) Human
LA Henze, M Estepa, B Pieske, F Lang, KU Eckardt, I Alesutan, J Voelkl Zinc Ameliorates the Osteogenic Effects of High Glucose in Vascular Smooth Muscle Cells Cells, 2021-11-09;10(11):. 2021-11-09 [PMID: 34831306] (Human) Human
A Larsson, J Helmersson, L Lind, J Ärnlöv, TR Feldreich Strong Associations between Plasma Osteopontin and Several Inflammatory Chemokines, Cytokines, and Growth Factors Biomedicines, 2021-07-28;9(8):. 2021-07-28 [PMID: 34440113] (Human) Human
R Urbanavi?i, R Zabitait?, A Kriš?iukai, VP Deltuva, D Skiriut? Serum protein triplet TGF-&beta1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma Scientific Reports, 2021-06-23;11(1):13100. 2021-06-23 [PMID: 34162919] (Human) Human
Show All 30 Publications.

Reviews for Osteopontin/OPN (DY1433) (0)

There are no reviews for Osteopontin/OPN (DY1433). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Osteopontin/OPN (DY1433) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Osteopontin/OPN Products

Blogs on Osteopontin/OPN.

Successful Transplantation of Friedreich Ataxia Induced Pluripotent Stem Cell (iPSC)-Derived Sensory Neurons in Dorsal Root Ganglia of Adult Rodents
Jamshed Arslan, Pharm D, PhD The dorsal root ganglia (DRG) are a collection of cell bodies of sensory nerves carrying sensory information – including nociception, mechanoreception and proprioception – from periphera...  Read full blog post.

Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Osteopontin (OPN) DuoSet ELISA, 15 Plate and receive a gift card or discount.

Bioinformatics

Gene Symbol SPP1